Tagrisso 80 mg Tablet
$2,316.82
$1,807.12
Tagrisso 80 mg Tablet is an effective treatment designed for adults diagnosed with non-small cell lung cancer (NSCLC), particularly in cases linked to specific genetic alterations known as EGFR mutations. This targeted therapy functions by inhibiting the activity of a particular protein kinase, which is crucial in promoting the proliferation of cancer cells, thereby slowing their growth and spread. Patients using Tagrisso should be aware of potential side effects, including diarrhea, rash, and respiratory issues, and should consult their healthcare provider for guidance on managing these symptoms. It is essential to have prior genetic testing to confirm the presence of EGFR mutations before starting this medication, ensuring its suitability for the individual patient. As with any cancer treatment, continuous monitoring is vital to assess effectiveness and adjust the treatment plan as needed. Tagrisso represents a significant advancement in personalized cancer therapy, offering hope to those affected by this challenging condition. Always discuss the risks and benefits of this treatment with your oncologist to make an informed decision tailored to your health needs.
Quantity
Active Pharmaceutical Ingredient
Uses
• Tagrisso 80 mg tablet is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations. This medication works by inhibiting the growth of cancer cells, thereby slowing disease progression. It is particularly beneficial for patients whose cancer has worsened after previous treatments. Doctors often prescribe Tagrisso 80 mg tablet for its targeted action against certain genetic alterations.
• In addition to its role in treating advanced NSCLC, Tagrisso 80 mg tablet is also effective for patients with metastatic disease. This means it can help manage cancer that has spread beyond the original tumor site. The medication targets specific mutations that drive cancer growth, providing a more tailored approach to treatment. Many oncologists incorporate Tagrisso 80 mg tablet into their patients' treatment regimens for its efficacy in managing advanced cases.
• Tagrisso 80 mg tablet is usually taken once daily, making it convenient for patients to integrate into their routine. Consistent use is crucial for achieving the best outcomes, as it maintains therapeutic levels of the drug in the body. Healthcare providers emphasize adherence to the prescribed regimen to enhance treatment effectiveness. Patients often report improved quality of life while on Tagrisso 80 mg tablet, as it helps control symptoms related to lung cancer.
• The decision to use Tagrisso 80 mg tablet typically follows a thorough evaluation of the patient's cancer profile. Oncologists assess the presence of specific mutations, which can influence treatment decisions. This personalized approach allows for more effective management of lung cancer, addressing the unique characteristics of each patient's condition. Tagrisso 80 mg tablet is a crucial option in the arsenal against advanced lung cancer, providing hope for many patients.
Benefits
NSCLC (Non-small cell lung cancer): Non-small cell lung cancer is a significant type of lung cancer that impacts both smokers and non-smokers alike. Tagrisso 80 Tablet is a medication used to treat this type of cancer, either by itself or alongside other medications. It's powerful but can also be quite toxic, so it's essential to talk with your doctor about its potential risks and benefits. During treatment, it's best to steer clear of alcohol and make sure to drink plenty of water to stay hydrated.
Side Effects
Most side effects of Tagrisso 80 Tablet don't need medical attention and usually go away as your body gets used to the medication. If they continue or cause concern, talk to your doctor.
Most Common Side Effects
• Itching
• Fever
• Redness
• Rashes
• Dry mouth
• Backpain
• Tiredness
• Coughing
Common Side Effects
• Electrolyte imbalance
• Keratitis ( inflammation of the cornea of the eyes)
• Breathing difficulty
• Slurred speech
• Irregular heartbeat
• Altered sensorium
• Loss of coordination
• Double vision
• Heart failure ( Symptoms like slow /shallow breathing, shortness of breathing, pedal oedema)
How To Use
Tagrisso 80 mg Tablet comes in the form of oral tablets meant to be swallowed whole, just as your doctor instructs. Make sure to take it consistently as prescribed. Your doctor will determine how often and how much of the medicine you should take based on the seriousness of your condition and other relevant factors.
Safety Advice
• Alcohol: It's unclear if drinking alcohol is safe while taking Tagrisso 80 mg.Please test together along with your physician for advice.
• Kidney: Tagrisso 80 mg Tablet can be safely used by patients with kidney disease, and no changes to the dosage are necessary.
• Breastfeeding: Tagrisso 80 mg Tablet is likely unsafe to use while breastfeeding. Limited data suggests it may pass into breast milk and could harm the baby.
• Liver: Tagrisso 80 mg is safe for patients with liver disease, and no dose adjustment is needed.
• Pregnancy: Tagrisso 80 mg Tablet might not be safe to use during pregnancy. While there aren't many studies on humans, animal studies have shown it can harm the development of babies. Your doctor will consider both the benefits and risks before prescribing it. Be sure to talk to your doctor about it.
• Driving: Tagrisso 80 Tablet generally does not impact your ability to drive.